Silverback Therapeutics shares owned by Royce & Associates
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Royce & Associates
from 13F filings
Historical chart of Royce & Associates investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Royce & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by Royce & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $4.5M | 256k | 17.45 |
| 2025-03-31 | $8.1M | 643k | 12.58 |
| 2024-12-31 | $9.8M | 930k | 10.55 |
| 2024-09-30 | $10M | 692k | 14.50 |
| 2024-06-30 | $5.5M | 646k | 8.51 |
| 2024-03-31 | $5.7M | 559k | 10.22 |
| 2023-12-31 | $2.6M | 474k | 5.48 |
| 2023-09-30 | $1.8M | 464k | 3.78 |
| 2023-06-30 | $3.1M | 464k | 6.70 |
| 2023-03-31 | $2.0M | 304k | 6.51 |